(Q81240317)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18466171%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

review article

1 reference

title

Estimating the pathogen safety of manufactured human plasma products: application to fibrin sealants and to thrombin (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18466171%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

author name string

Bernard Horowitz

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18466171%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Michael Busch

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18466171%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

publication date

7 May 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18466171%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18466171%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

volume

48

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18466171%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18466171%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

page(s)

1739-1753

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18466171%20AND%20SRC:MED&resulttype=core&format=json

Removal/neutralization of hepatitis A virus during manufacture of high purity, solvent/detergent factor VIII concentrate

7 January 2020

cites work

1 reference

12 December 2020

Acquired FV inhibitors: a needless iatrogenic complication of bovine thrombin exposure

1 reference

12 December 2020

Factor VIII and transmissible spongiform encephalopathy: the case for safety

1 reference

12 December 2020

Frequency of transmission of human parvovirus B19 infection by fibrin sealant used during thoracic surgery

1 reference

12 December 2020

Inactivation of West Nile virus, vaccinia virus and viral surrogates for relevant and emergent viral pathogens in plasma-derived products

1 reference

12 December 2020

Removal of abnormal prion protein by plasma fractionation

1 reference

12 December 2020

Monoclonal antibodies can reveal immunoreactivity differences between pituitary and recombinant bovine growth hormone

1 reference

12 December 2020

Amplified transmission of HIV-1: comparison of HIV-1 concentrations in semen and blood during acute and chronic infection

1 reference

12 December 2020

Parvovirus B19 DNA in plasma pools and plasma derivatives

1 reference

12 December 2020

Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda

1 reference

12 December 2020

Minimum infectious dose of hepatitis B virus in chimpanzees and difference in the dynamics of viremia between genotype A and genotype C.

1 reference

12 December 2020

Antiphospholipid antibodies after surgical exposure to topical bovine thrombin

1 reference

12 December 2020

Mass spectrometrical analysis of recombinant human growth hormone (Genotropin(R)) reveals amino acid substitutions in 2% of the expressed protein

1 reference

12 December 2020

Lengths of hepatitis B viremia and antigenemia in blood donors: preliminary evidence of occult (hepatitis B surface antigen-negative) infection in the acute stage

1 reference

12 December 2020

Ultrapure plasma factor VIII produced by anti-F VIII c immunoaffinity chromatography and solvent/detergent viral inactivation. Characterization of the Method M process and Hemofil M antihemophilic factor (human).

1 reference

12 December 2020

Fibrin sealants in surgical practice: An overview

1 reference

12 December 2020

Very low level viremia in HCV infectious unit missed by NAT

1 reference

12 December 2020

Inactivation and elimination of viruses during preparation of human intravenous immunoglobulin

1 reference

12 December 2020

Quantification of hepatitis B virus genomes and infectivity in human serum samples

1 reference

12 December 2020

Human erythrovirus B19 and blood transfusion - an update

1 reference

12 December 2020

Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient

1 reference

12 December 2020

Risk and clinical significance of developing antibodies induced by topical thrombin preparations

1 reference

12 December 2020

The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study

1 reference

12 December 2020

Coagulation factor concentrates: past, present, and future.

1 reference

12 December 2020

Treatment of malignant carcinoid tumors with recombinant interferon alfa-2b: development of neutralizing interferon antibodies and possible loss of antitumor activity

1 reference

12 December 2020

Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection

1 reference

12 December 2020

Efforts in minimizing risk of viral transmission through viral inactivation

1 reference

12 December 2020

Yield of HCV and HIV-1 NAT after screening of 3.6 million blood donations in central Europe

1 reference

12 December 2020

Frequent detection of the parvoviruses, PARV4 and PARV5, in plasma from blood donors and symptomatic individuals

1 reference

12 December 2020

A probabilistic model for analyzing viral risks of plasma-derived medicinal products

1 reference

12 December 2020

Parvovirus B19: implications for transfusion medicine. Summary of a workshop

1 reference

12 December 2020

Removal of viruses from plasma fractions by chromatography

1 reference

12 December 2020

Inactivation of parvovirus B19 during pasteurization of human serum albumin.

1 reference

12 December 2020

Heat sensitivity of a SARS-associated coronavirus introduced into plasma products

1 reference

12 December 2020

Contributions to the optimal use of human blood. IX. Elimination of hepatitis B transmission by (potentially) infectious plasma derivatives

1 reference

12 December 2020

Alpha-1-antitrypsin replacement therapy: current status

1 reference

12 December 2020

Fibrinogen and fibrin structure and functions

1 reference

12 December 2020

Blood donor screening for parvovirus B19 in Germany and Austria.

1 reference

12 December 2020

Creutzfeldt-Jakob disease and blood transfusion: results of the UK Transfusion Medicine Epidemiological Review study

1 reference

12 December 2020

Intravenous immunoglobulin and Alzheimer's disease immunotherapy.

1 reference

12 December 2020

Clinical presentation and pre-mortem diagnosis of variant Creutzfeldt-Jakob disease associated with blood transfusion: a case report.

1 reference

12 December 2020

Large-scale preparation of highly purified human C1-inhibitor for therapeutic use

1 reference

12 December 2020

Second-generation nanofiltered plasma-derived mannan-binding lectin product: process and characteristics

1 reference

12 December 2020

Specific inactivation of viruses which can potentially contaminate blood products

1 reference

12 December 2020

Assessment of the potential of plasma fractionation processes to remove causative agents of transmissible spongiform encephalopathy

1 reference

12 December 2020

Distribution of a bovine spongiform encephalopathy-derived agent over ion-exchange chromatography used in the preparation of concentrates of fibrinogen and factor VIII.

1 reference

12 December 2020

Thermal inactivation of human immunodeficiency virus in lyophilised blood products evaluated by ID50 titrations

1 reference

12 December 2020

1 reference

12 December 2020

Human plasma fibronectin potentiates the mitogenic activity of platelet-derived growth factor and complements its wound healing effects

1 reference

12 December 2020

Equilibrium centrifugation studies of hepatitis C virus: evidence for circulating immune complexes

1 reference

12 December 2020

West Nile virus and the safety of plasma derivatives: verification of high safety margins, and the validity of predictions based on model virus data

1 reference

12 December 2020

Failure of a human immunodeficiency virus (HIV) immune globulin to protect chimpanzees against experimental challenge with HIV

1 reference

12 December 2020

Hepatitis C virus replication kinetics in chimpanzees with self-limited and chronic infections

1 reference

12 December 2020

Antihuman factor V antibodies after use of relatively pure bovine thrombin

1 reference

12 December 2020

Current prevalence and incidence of infectious disease markers and estimated window-period risk in the American Red Cross blood donor population

1 reference

12 December 2020

Chromatography in plasma fractionation: benefits and future trends

1 reference

12 December 2020

Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion

1 reference

12 December 2020

The safety of fibrin sealants

1 reference

12 December 2020

Intravenous immunoglobulin in immunodeficiency states: state of the art.

1 reference

12 December 2020

Thermal inactivation of animal viruses

1 reference

12 December 2020

Parvovirus B19 DNA in Factor VIII concentrates: effects of manufacturing procedures and B19 screening by nucleic acid testing.

1 reference

12 December 2020

A new strategy for estimating risks of transfusion-transmitted viral infections based on rates of detection of recently infected donors

1 reference

12 December 2020

Screening the blood supply for West Nile virus RNA by nucleic acid amplification testing

1 reference

12 December 2020

Heat sensitivity of human parvovirus B19.

1 reference

12 December 2020

Parvovirus B19 transmission by a high-purity factor VIII concentrate

1 reference

12 December 2020

Viral safety of Nanogam, a new 15 nm-filtered liquid immunoglobulin product

1 reference

12 December 2020

Detection of variant Creutzfeldt-Jakob disease infectivity in extraneural tissues

1 reference

12 December 2020

Implementation of donor screening for infectious agents transmitted by blood by nucleic acid technology: update to 2003.

1 reference

12 December 2020

Studies on the removal of a bovine spongiform encephalopathy-derived agent by processes used in the manufacture of human immunoglobulin

1 reference

12 December 2020

Detection of HIV-1 and HCV infections among antibody-negative blood donors by nucleic acid-amplification testing

1 reference

12 December 2020

Capillary electrophoresis with laser-induced fluorescence detection for detailed studies on N-linked oligosaccharide profile of therapeutic recombinant monoclonal antibodies

1 reference

12 December 2020

Assessing the impact of HBV NAT on window period reduction and residual risk

1 reference

12 December 2020

Dynamics of viremia in early hepatitis C virus infection

1 reference

12 December 2020

Current strategies to prevent transmission of prions by human plasma derivatives

1 reference

12 December 2020

Studies on the removal of abnormal prion protein by processes used in the manufacture of human plasma products

1 reference

12 December 2020

Amplified HIV transmission and new approaches to HIV prevention

1 reference

12 December 2020

Exposure of mice to topical bovine thrombin induces systemic autoimmunity

1 reference

12 December 2020

Infectivity of blood components with low hepatitis B virus DNA levels identified in a lookback program

1 reference

12 December 2020

Immunologic impact and clinical outcomes after surgical exposure to bovine thrombin

1 reference

12 December 2020

Titration of hepatitis C virus in chimpanzees for determining the copy number required for transmission

1 reference

12 December 2020

Antibodies developing against a single recombinant interferon protein may neutralize many other interferon-alpha subtypes.

1 reference

12 December 2020

Blood protein derivative viral safety: observations and analysis

1 reference

12 December 2020

H5N1 influenza virus and the safety of plasma products.

1 reference

12 December 2020

The epidemiology of virus transmission by plasma derivatives: clinical studies verifying the lack of transmission of hepatitis B and C viruses and HIV type 1.

1 reference

12 December 2020

Neutralization of human parvovirus B19 by plasma and intravenous immunoglobulins

1 reference

12 December 2020

The Immune Response to Parvovirus B19 Exposure in Previously Seronegative and Seropositive Individuals

1 reference

12 December 2020